Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 1998

View Archived Issues

Company Profile: Introgen Therapeutics

T Cell Sciences receives patent on new compound

New anticancer agent capable of eluding tumor resistance mechanisms

C. pneumoniae antibody titers correlated to stroke and cerebral ischemia

NOS inhibition with L-NMMA reduces CBF in humans

Cortex: Q2 fiscal 1998 highlights

Electroporation therapy results in at least 80% reduction in tumor volume in preclinical studies

Neurocrine Biosciences: Q4 and FY 1997 highights

TRH ineffective as treatment for lung problems in premature infants

Osiris and the University of Cincinnati expand collaboration in tendon regeneration

Biosearch Italia and Versicor establish infectious disease collaboration

Biogen sets up Canadian office to promote local development of Avonex

FDA advisory committee to vote on expanded label for CEPRATE SC System

Selective inhibitor of p38 MAP kinase effective in chronic inflammatory diseases

Nucleoside with potent and selective anti-HIV and anti-HBV activity

Tedisamil has favorable profile as myocardial antiischemic agent

Azithromycin prevents acceleration of atherosclerosis by C. pneumoniae infection

Roche acquisition of Corange approved by U.S. regulators

Another market introduction for Aricept

Lead compound from ABS shows promise for neurodegenerative disorders

Nonsteroidal human progesterone receptor agonists developed at Ligand

Improved vision in AMD patients in phase I/II using PhotoPoint technology

Dolasetron now available in U.S.

Orthovisc PMA accepted for filing by FDA

Glycomed antiinflammatory patents licensed to Cytel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...